OCT 01, 2015 9:00 AM PDT

Engaging the Patient in the Treatment Journey

Speakers
  • Executive Director, Melanoma Research Foundation
    Biography
      Tim Turnham became the Executive Director of the Melanoma Research Foundation (MRF) in January 2009. Tim shares the MRF's commitment to supporting medical research to find more effective treatments and eventually a cure for melanoma and brings more than 30 years of experience in management, fundraising, communication, teaching and research.

      Prior to joining the MRF, Tim served as Chief Executive Officer of the Colon Cancer Alliance as well as Director of Development for United Cerebral Palsy Associations. He has also served as the Director of Development for the Whitman-Walker Clinic and as Director of Development at the Children's Research Institute.

      Tim holds a B.A. in Microbiology from the University of Tennessee, a M. Div. from the New Orleans Baptist Theological Seminary and a Ph.D. from the Southern Baptist Theological Seminary.

      Tim lives in Washington, D.C. with his wife Phyllis. They have three adult children
    • Director of Education, Melanoma Research Foundation
      Biography
        Shelby Moneer joined the MRF team in August of 2010 to oversee the education program. As the Director of Education, Shelby is responsible for all development, implementation and assessment of the education program. This includes patient/caregiver education, clinician education, primary and secondary prevention efforts, print materials, awareness campaigns, website content, over-the-phone patient navigation and all patient resources and communication. These programs range from in-person events, virtual events and include a wide variety of print materials, all of which are free to the public. Shelby is also the manager of the MRF's research grant program.

        Shelby holds a bachelor's degree in Exercise Science and a master's degree in Health Education. Her previous experience was in the non-profit development, implementation and assessment of tobacco-related education, prevention and treatment strategies in the Florida Panhandle. She was a collegiate volleyball and softball player and continues playing beach volleyball whenever she can. Shelby and her husband, Steve, have a 3 year old daughter and live in Spokane, WA. They enjoy playing and watching sports, spending time outdoors and being surrounded with friends and family.

      Abstract

      This is an exciting time for melanoma treatment, with a half-dozen new drugs approved in just over four years. This influx has brought a new complexity to the field, however, including questions about which drugs to give which patients, in what order to give those drugs, and in what combination they can be given. The rapid rise of immunotherapy drugs has introduced a new type of side effect profile that further complicates treatment. One overlooked result of these changes is the need for a new level of communication between patients and their health care team. Data is clear that patients who are well informed and well supported live longer and better, but what does that look like in the current treatment landscape.
       


      Show Resources
      You May Also Like
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      SEP 03, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 03, 2020 9:00 AM PDT
      DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      DEC 03, 2020 4:30 PM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      DEC 03, 2020 4:30 PM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      Loading Comments...
      Show Resources
      Attendees
      • See more